A canine model of multiple portosystemic shunting

Journal of Investigative Surgery

Volumn 13, Issue 1, 2000, Pages 45-57

  Howe, Lisa M ^a   Boothe Jr , Harry W ^a   Miller, Matthew W ^a   Boothe, Dawn M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Canine; Dimethylnitrosamine; Disease model; Hepatic cirrhosis; Hepatic disease; Portal hypertension; Portosystemic shunting

Indexed keywords

DIMETHYLNITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LIVER BIOPSY; LIVER SCINTISCANNING; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; ULTRASOUND;

EID: 0033954823     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/089419300272258     Document Type: Article

References (40)

1. Boothe DM, Jenkins WL, Green RA, Corrier DE, Cullen JM, Boothe HW, Weise D. Dimethylnitrosamine-induced hepatotoxicosis in dogs as a model of progressive canine hepatic disease. Am J Vet Res. 1992;53:411-420.
2. Madden JW, Gertman PM, Peacock EE. Dimethylnitrosamine-induced hepatic cirrhosis: A new canine model of an ancient human disease. Surgery. 1970;68: 260-268.
3. Lake BG, Collins MA, Harris RA, Phillips JC, Cottrell RC, Gangolli SD. Studies on the metabolism of dimethylnitrosamine in vitro by rat liver preparations. I. Comparison with mixed function oxidase enzymes. Xenobiotica. 1982a;12:435-445.
4. Kroeger-Koepke MB, Koepke SR, McClusky GA, Magee PN, Michejda CJ. Alpha-hydroxylation pathway in the in vitro metabolism of carcinogenic nitrosamines: N-Nitrosodimethylamine and N-nitroso-N-methylaniline. Proc Natl Acad Sci USA. 1981;78:6489-6493.
5. Magee PN, Barnes JM. Carcinogenic nitroso compounds. Adv Cancer Res. 1967;10:163-247.
6. Mirvish SS. N-Nitroso compounds: Their chemical and in vivo formation and possible importance as environmental carcinogens. J Toxicol Environ Health. 1977;2:1267-1277.
7. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T. Preventative and therapeutic effects in rats of heaptocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 1997;26:81-89.
8. George J, Chandrakasan G. Glyocprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol. 1996;28:353-361.
9. Testas P, Benichou J, Perrin N, Vieillefond A, Benhanou M. Comparative study of two models for experimental cirrhosis in the dog. Eur Surg Res. 1978;10:146-152.
10. Ryhanen L, Stenback F, Ala-Kokko L, Savolainen ER. The effect of malotilate on type III and type IV collagen, laminim and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat. J Hepatol. 1996;24:238-245.
11. Preussman R, Weissle M. The enigma of organ-specificity of carcinogenic nitrosamines. Trends Pharm Sci. 1987;8:185-189.
12. Mukherjee T, Gustafsson RG, Afzelius BA, Arrhenius E. Effects of carcinogenic amines on amino acid incorporation by liver systems. II. A morphologic and biochemical study on the effect of dimethylnitrosamine. Cancer Res. 1963;23:944-953.
13. Korsrud GO, Grice HG, Goodman TK, Knipfel JE, McLaughlan JM. Sensitivity of several serum enzymes for the detection of thioacetamine-, dimethylnitrosamine- and diethylolamine-induced liver damage in rats. Toxicol Appl Pharmacol. 1973;26:299-313.
14. Butler-Howe LM, Boothe HW, Boothe DM, Laine GA, Calvin JA. Effects of vena caval banding in experimentally induced multiple portosystemic shunts in dogs. Am J Vet Res. 1993;54:1774-1783.
15. Howe LM, Boothe DM, Boothe HW. Endotoxemia associated with experimentally induced multiple portosystemic shunts in dogs. Am J Vet Res. 1997;58:83-88.
16. Boothe DM, Brown SA, Jenkins WL, Green RA, Cullen JM, Corrier DE. Indocyanine green disposition in healthy dogs and dogs with mild, moderate, or severe dimethylnitrosamine-induced hepatic disease. Am J Vet Res. 1992;53:382-388.
17. Wrigley RK, Konde LJ, Park RD, Lebel JL. Ultrasonographic diagnosis of portocaval shunts in young dogs. J Am Vet Med Assoc. 1987;191:421-424.
18. Koblik PD, Hornoff WJ, Breznock EM. Quantitative hepatic scintigraphy in the dog. Vet Radiol. 1983;24:226-231.
19. Koblik PD, Hornoff WJ, Breznock EM. Use of quantitative hepatic scintigraphy to evaluate spontaneous portosystemic shunts in 12 dogs. Vet Radiol. 1983;24:232-236.
20. Moon ML. Diagnostic imaging of portosystemic shunts. Semin Vet Med Surg (Small Anim). 1990;5:120-126.
21. Butler LM, Fossum TW, Boothe HW. Surgical management of extrahepatic portosystemic shunts in the dog and cat. Semin Vet Med Surg (Small Anim). 1990;5:127-133.
22. Whiting PG, Peterson SL. Portocaval shunts. In: Slatter D, ed. Textbook of Small Animal Surgery (2nd ed). Philadelphia: WB Saunders; 1993:660-677.
23. Rozga J, Foss A, Alumets J, Ahrens B, Jeppsson B, Bengmark S. Liver cirrhosis in rats: Regeneration and assessment of the role of phenobarbital. J Surg Res. 1991;51:329-335.
24. 4-induced hepatic cirrhosis. Lab Anim. 1991;25:21-25.
25. Torres EM, Bouza JIP, Hernandez MMA, Martin MJA, Bravo AL. Experimental carbon tetrachloride-induced cirrhosis of the liver. Int J Tiss Reac. 1988;10:245-251.
26. 4induced liver cirrhosis. J Surg Res. 1997;70:124-133.
27. Mion F, Geloen A, Agosto E, Minaire Y. Carbon tetrachloride-induced cirrhosis in rats: Influence of the acute effects of the toxin on glucose metabolism. Hepatology. 1996;23:582-588.
28. Koblik PD, Hornoff WJ, Yen C, Komtebedde J, Breznock E, Fisher P. Comparison of shunt fraction estimation using transcolonic iodine-123-iodoamphetamine and technetium-99m-pertechnetate in a group of dogs with experimentally-induced chronic biliary cirrhosis. J Nuc Med. 1991;32:124-129.
29. Morgan TR, Morgan K, Jonas G, Thillainadarajah I. Atrial natriuretic factor in experimental cirrhosis in rats. Gastroenterology. 1992;102:1356-1362.
30. Oberti F, Pilette C, Rifflet H, Maiga MY, Moreau A, Gallois Y, Girault A, le Bouil A, Le Jeune JJ, Saumet JL, Feldmann G, Cales P. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 1997;26:1363-1371.
31. Criado M, Flores O, Ortiz MC, Hidalgo F, Rodriguez-Lopez AM, Eleno N, Atucha NM, Sanchez-Rodriguez A, Arevalo M, Garcia-Estan J, Lopez-Novoa JM. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation. Hepatology. 1997;26:268-276.
32. Wong J, Zhang Y, Lee SS. Effects of portacaval shunting hyperdynamic circulation in bile duct-ligated cirrhotic rats. J Hepatol. 1997;26:369-375.
33. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate: A model of experimental hemochromatosis. Am J Pathol. 1979;95:663-674.
34. Toyokuni S, Okado S, Hamazaki S, Fujioka M, Li JL, Midorikawa O. Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats: An experimental model of copper toxicosis: Am J Pathol. 1989;134:1263-1274.
35. Muller A, Machnik F, Zimmerman T, Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats - Usefulness and reliability of this animal model. Exp Pathol. 1988;34:229-236.
36. Buko V, Lukivskaya O, Nikitin V, Kuryan A, Dargel R. Antioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis. Exp Toxicol Pathol. 1997;49:141-146.
37. Torres MI, Fernandez MI, Gil A, Rios A. Effect of dietary nucleotides on degree of fibrosis and steatosis induced by oral intake of thioacetamide. Dig Dis Sci. 1997;42:1322-1328.
38. Terpstra OT, van Vroonhoven TJ, van Vroonhoven MV, Noordhoek J, ten Kate FJ, Wilson JH. Temporary beneficial effect of arterialization of the liver in cirrhotic dogs with portocaval shunt. Eur Surg Res. 1982;14:333-343.
39. Grilli S, Prodi G. Identification of dimethylnitrosamine metabolites in vitro. Jpn J Cancer Res. 1975;66:473-480.
40. Boothe HW, Howe LM, Edwards JF, Slater MR. Multiple extrahepatic portosystemic shunts in dogs: 30 Cases (1981-1993). J Am Vet Med Assoc. 1996;208:1849-1854.